An extensive look into CSER1's experiences with secondary findings reveals how SFs impact unrecognized family history, causes little distress on patients, and induce modest 1-year downstream costs. Read more »
Out now, the CSER Marker Paper, describing the work of CSER in addressing evidence gaps in delivering genomics in non-academic settings and diverse populations. Read more »
Six sites and one coordinating center are funded as part of CSER. Focusing on diverse populations, sites seek to generate evidence supporting use of genomic sequencing in medical care. Read more »
